HB1302
To Add Duchenne Muscular Dystrophy To The Universal Newborn Screening Act.
Last Action (Jan. 29, 2025): WITHDRAWN BY AUTHOR
Sponsors
AI-Generated Summary
House Bill 1302 seeks to amend the Universal Newborn Screening Act in Arkansas to include Duchenne muscular dystrophy in the list of mandatory screenings for all newborn infants. Under current law, newborns are screened for core medical conditions recommended by the United States Secretary of Health and Human Services. This bill codifies the requirement for testing specifically for Duchenne muscular dystrophy in addition to those federal recommendations. The primary purpose is to ensure earlier detection of this genetic disorder to facilitate timely medical intervention and improve health outcomes for infants born with the condition.
Potential Impact Analysis
Who Might Benefit?
Newborn infants in Arkansas who may have Duchenne muscular dystrophy will directly benefit from early detection, allowing for earlier access to potential treatments and interventions. Families of these infants benefit by receiving critical medical information sooner, which can improve long-term care management and health outcomes.
Who Might Suffer?
The Arkansas Department of Health and healthcare providers, including hospitals and laboratories, may be negatively impacted as they would incur additional administrative, logistical, and financial costs associated with implementing and performing the new mandatory screening test. Furthermore, the state's budget may be affected by the need to allocate additional resources to cover the expansion of the screening program.
Get Notified
Receive an email when this bill's status changes.